Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients

OncoImmunology

Volumn 1, Issue 5, 2012, Pages 694-698

  Pieraerts, Claire ^a   Martin, Virginie ^a   Jichlinski, Patrice ^a   Nardelli Haefliger, Denise ^a   Derré, Laurent ^a  

^a Department of Urology   (Czech Republic)

Author keywords

BCG therapy; Bladder cancer; IFNc ELISPOT; T cells

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ANTIGEN SPECIFICITY; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER PATIENT; ENZYME LINKED IMMUNOSPOT ASSAY; IMMUNOCOMPETENT CELL; IN VITRO STUDY; LYMPHOCYTE COUNT; PRIORITY JOURNAL; T LYMPHOCYTE; URINE;

EID: 84886943618     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.20526     Document Type: Article

References (21)

1. Metts MC, Metts JC, Milito SJ, Thomas CR, Jr. Bladder cancer: a review of diagnosis and management. J Natl Med Assoc 2000; 92:285-94; PMID:10918764
2. Utz DC, Farrow GM. Management of carcinoma in situ of the bladder: the case for surgical management. Urol Clin North Am 1980; 7:533-41; PMID:7456165 3. Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 1976; 116:180-3; PMID: 820877
3. Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 1976; 116:180-3; PMID: 820877
4. Schenk-Braat EA, Bangma CH. Immunotherapy for superficial bladder cancer. Cancer Immunol Immunother 2005; 54:414-23; PMID:15565330; http://dx.doi.org/10.1007/s00262-004-0621-x
5. Totterman TH, Loskog A, Essand M. The immunotherapy of prostate and bladder cancer. BJU Int 2005; 96:728-35; PMID:16144528; http://dx.doi.org/10. 1111/j.1464-410X.2005.05772.x
6. Bisiaux A, Thiounn N, Timsit MO, Eladaoui A, Chang HH, Mapes J, et al. Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus calmette-guerin therapy in patients with superficial bladder cancer. J Urol 2009; 181:1571-80; PMID:19230924; http://dx.doi.org/10.1016/j.juro. 2008.11.124
7. Bredan R, Bisiaux A, Biot C, Rentsch CA, Bousso P, Albert ML. Mathematical model of tumor immunotherapy for bladder carcinoma identifies the limitations of the innate immune response. OncoImmunology 2012; 1:9-17; http://dx.doi.org/10.4161/onci.1.1.17884 8. Ratliff TL. Role of the immune response in BCG for bladder cancer. Eur Urol 1992; 21(Suppl 2):17-21; PMID:1396942
8. Ratliff TL. Role of the immune response in BCG for bladder cancer. Eur Urol 1992; 21(Suppl 2):17-21; PMID:1396942
9. Stachowski J, Barth C, Lewandowska-Stachowiak M, Lammerding P, Runowski D, Baldamus CA. Flow cytometric analysis of urine lymphocytes isolated from patients with renal transplants-purification of urine lymphocytes. J Immunol Methods 1998; 213:145-55; PMID:9692847; http://dx.doi.org/10.1016/S0022-1759(98)00013-1
10. de Boer EC, de Jong WH, van der Meijden AP, Steerenberg PA, Witjes F, Vegt PD, et al. Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis. Urol Res 1991; 19:45-50; PMID:2028562; http://dx. doi.org/10.1007/BF00294021
11. De Boer EC, De Jong WH, Van Der Meijden AP, Steerenberg PA, Witjes JA, Vegt PD, et al. Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin. Cancer Immunol Immunother 1991; 33:411-6; PMID: 1878894; http://dx.doi.org/10.1007/BF01741603
12. Derré L, Jandus C, Baumgaertner P, Posevitz V, Devêvre E, Romero P, et al. Quantitative multiparameter assays to measure the effect of adjuvants on human antigen-specific CD8 T-cell responses. Methods Mol Biol 2010; 626:231-49; PMID:20099132; http:// dx.doi.org/10.1007/978-1-60761-585-9_16
13. Brunst M, Shahmanesh M, Sukthankar A, Pearce JH, Gaston JS. Isolation and characterisation of T lymphocytes from the urethra of patients with acute urethritis. Sex Transm Infect 1998; 74:279-83; PMID:9924470; http://dx.doi.org/10.1136/sti.74.4.279
14. Siracusano S, Vita F, Abbate R, Ciciliato S, Borelli V, Bernabei M, et al. The role of granulocytes following intravesical BCG prophylaxis. Eur Urol 2007; 51:1589-97, discussion 1597-9; PMID:17222501; http://dx.doi. org/10.1016/j.eururo.2006.11.045
15. Suttmann H, Riemensberger J, Bentien G, Schmaltz D, Stöckle M, Jocham D, et al. Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses. Cancer Res 2006; 66:8250-7; PMID: 16912205; http://dx.doi.org/10.1158/0008-5472.CAN- 06-1416
16. Brandau S, Trellakis S, Bruderek K, Schmaltz D, Steller G, Elian M, et al. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol 2011; 89:311-7; PMID: 21106641; http://dx.doi.org/10.1189/jlb.0310162
17. Moodie Z, Price L, Gouttefangeas C, Mander A, Janetzki S, Löwer M, et al. Response definition criteria for ELISPOT assays revisited. Cancer Immunol Immunother 2010; 59:1489-501; PMID:20549207; http://dx.doi.org/10.1007/s00262-010-0875-4
18. Lanzavecchia A, Roosnek E, Gregory T, Berman P, Abrignani S. T cells can present antigens such as HIV gp120 targeted to their own surface molecules. Nature 1988; 334:530-2; PMID:2841610; http://dx.doi.org/ 10.1038/334530a0
19. Decrausaz L, Revaz V, Bobst M, Corthésy B, Romero P, Nardelli-Haefliger D. Induction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated mice. Int J Cancer 2010; 126:2469-78; PMID:19816937
20. Piersma SJ, Jordanova ES, van Poelgeest MI, Kwappenberg KM, van der Hulst JM, Drijfhout JW, et al. High number of intraepithelial CD8+ tumorinfiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large earlystage cervical cancer. Cancer Res 2007; 67:354-61; PMID:17210718; http://dx.doi.org/10.1158/0008-5472.CAN-06-3388
21. Revaz V, Debonneville A, Bobst M, Nardelli-Haefliger D. Monitoring of vaccine-specific gamma interferon induction in genital mucosa of mice by real-time reverse transcription-PCR. Clin Vaccine Immunol 2008; 15:757-64; PMID:18367582; http://dx.doi.org/10. 1128/CVI.00392-07 698